PALLD and thyroid cancer: Our expression analysis of 25 organs revealed significant upregulation of palladin in bile duct, brain, breast, liver, lung, pancreas, stomach, and thyroid cancers; and downregulation in tumors of the bladder, cervix, colon, endometrium, esophagus, ovary, prostate, rectum, skin, testis, and uterus.